Login to Your Account



Clinical Data Soars on Viibryd Depression Nod, Sale Talk

By Jennifer Boggs


Tuesday, January 25, 2011
Shares of Clinical Data Inc. skyrocketed 67.5 percent Monday after the FDA's late Friday approval of vilazodone in major depressive disorder quieted skeptics and positioned the Newton, Mass.-based firm as a potential takeover target.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription